Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined atropine plus patching versus patching alone for severe amblyopia in children
ChiCTR1800018663Phase 4Not yet recruiting
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Nov 2018
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atropine in amblyopia (2 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoint: visual acuity. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
amblyopia
Beyond the preview
Go deeper on ChiCTR1800018663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018663.